GridAI Technologies Corp. (GRDX)
NCM · Healthcare · Biotechnology
$2.86
-3.70%
Closing price as of 2026-09-11 · Source: TEK2day Finance
Key Metrics
Market Cap
$20.4M
Shares Outstanding
7.1M
P/S (TTM)
127x
Exchange
NCM
Currency
USD
About GridAI Technologies Corp.
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 36K | 38K | 86K |
| Gross Profit | (614K) | (37K) | ||
| Operating Income | (935K) | (4.7M) | (3.6M) | (3.0M) |
| Net Income | (1.2M) | (3.0M) | (3.6M) | (12.8M) |
| Diluted EPS | $-0.75 | N/A | $-0.82 | $-2.01 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 36K |
| Gross Profit | 0.00 | (657K) | ||
| Operating Income | (12.7M) | (15.8M) | (15.6M) | (7.1M) |
| Net Income | (14.6M) | (15.8M) | (18.1M) | (6.4M) |
| Diluted EPS | $-1,250.82 | $-143.64 | $-15.99 | $-4.16 |